- Ana Sayfa
- Uygulama Analitiği
- Guía de Linfoma de GELTAMO
- Guía de Linfoma de GELTAMO Vs. Trialing
Guía de Linfoma de GELTAMO vs Trialing Kullanım & İstatistikleri
This mobile app with Interactive Guides in Lymphoma has been developed by the Spanish Research Group specialized in Lymphomas (GELTAMO).
These interactive guides have been prepared and reviewed by leading lymphoma experts and are grounded in evidence-based medicine findings, providing a comprehensive set of recommendations for medical professionals to help patients with the best care options.
This app must be able to be used in mobile devices by medical professionals in geographic areas without Internet connection and medical centers isolated installations without Internet connection such us nuclear medicine, radiotherapy rooms among others.
- Apple App Store
- BOŞTA
- Medikal
Mağaza Sıralaması
- -
Trialing is a platform that helps doctors easily find the most suitable clinical trial for their patients and establish direct contact with the principal investigator. No delays or bureaucracy.
We work with reviewed, organized, and categorized data. At Trialing, we don't settle for just showing the features of clinical trials; we go into detail.
Thanks to our network of healthcare professionals, we know precisely which hospitals are recruiting. This way, you can choose the most appropriate hospital to refer your patient to.
At Trialing, we offer the opportunity to contact the destination center directly: no intermediaries and no delays.
- Apple App Store
- BOŞTA
- Medikal
Mağaza Sıralaması
- -
Guía de Linfoma de GELTAMO ile Trialing için sıralama karşılaştırması
Son 28 gündeki Guía de Linfoma de GELTAMO sıralama trendini Trialingile karşılaştırın
Rank
Mevcut veri yok
Guía de Linfoma de GELTAMO vs. Trialing ülke karşılaştırmasına göre sıralama
Son 28 gündeki Guía de Linfoma de GELTAMO sıralama trendini Trialingile karşılaştırın
Gösterilecek bilgi yok
Ücretsiz deneme sürümümüzü kullanarak istediğiniz siteyle karşılaştırın
Guía de Linfoma de GELTAMO VS.
Trialing
Aralık 13, 2024